Reported Q: Q2 2025 Rev YoY: +5.3% EPS YoY: -38.6% Move: -0.13%
Revvity Inc
0KHE.L
$99.45 -0.13%
Exchange LSE Sector Healthcare Industry Medical Diagnostics Research
Q2 2025
Published: Aug 5, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 0KHE.L

Reported

Report Date

Aug 5, 2025

Quarter Q2 2025

Revenue

720.28M

YoY: +5.3%

EPS

0.47

YoY: -38.6%

Market Move

-0.13%

Previous quarter: Q1 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $720.28M up 5.3% year-over-year
  • EPS of $0.47 decreased by 38.6% from previous year
  • Gross margin of 54.5%
  • Net income of 55.22M
  • "" -
0KHE.L
Company 0KHE.L

Executive Summary

Revvity Inc delivered a solid QQ2 2025 performance with meaningful top-line growth anchored by its Diagnostics and Discovery platforms. Revenue reached $720.3 million, up 5.3% year over year and 8.3% quarter over quarter, while gross margin held strong at 54.5%, yielding gross profit of $392.6 million. EBITDA stood at $194.4 million and operating income was $90.8 million, resulting in an operating margin of 12.6% and a net margin of 7.7% on the quarter. Net income was $55.2 million, or $0.47 per share, reflecting ongoing operating efficiency alongside continued investment spend.

Key Performance Indicators

Revenue
Increasing
720.28M
QoQ: 8.35% | YoY: 5.30%
Gross Profit
Increasing
392.56M
54.50% margin
QoQ: 19.96% | YoY: 2.01%
Operating Income
Decreasing
90.76M
QoQ: 3.17% | YoY: -11.54%
Net Income
Decreasing
55.22M
QoQ: 33.27% | YoY: -41.23%
EPS
Decreasing
0.47
QoQ: 36.27% | YoY: -38.57%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 772.06 0.87 +5.9% View
Q3 2025 698.95 0.40 -4.2% View
Q2 2025 720.28 0.47 +5.3% View
Q1 2025 664.76 0.34 -2.8% View
Q4 2024 729.37 0.78 +5.5% View